Study of two drugs in healthy volunteers
This trial tests how two experimental drugs, IN-M00007 and IN-R00007, move through the body and how safe they are. It is for healthy adults to gather basic information before testing in patients.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 19 and 59 years old.
- Your body mass index (BMI) is between 18.0 and 30.0.
- If you are male, you weigh at least 50 kg; if female, at least 45 kg.
- You are generally healthy, with no major diseases or abnormal test results.
- You agree to use highly effective birth control (like an IUD or abstinence) from the start of the study until 14 days after the last dose, and you will not donate sperm or eggs during this time.
- You have not taken certain medications or supplements that affect drug metabolism in the past 30 days, and have not participated in another drug trial in the past 6 months.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new oral medication, VG290131, in healthy volunteers to see how the body processes it and if it is safe. It is an early-phase trial that requires participants to be in good health and follow specific rules about medications and lifestyle.
This early-stage study tests a new experimental drug called LG-0317 in healthy volunteers to see if it is safe and how the body processes it. If you are healthy and meet the basic requirements, this trial may help advance a new treatment option.
This study tests a new medicine called INS1033 in healthy people to see if it is safe and how the body handles it. It is an early-stage study and does not involve treating any disease.
This trial tests a new drug called IPG1094 in healthy people to see if it's safe and how the body handles it. Healthy volunteers may join to help find the right dose for future studies.
This is an early-stage safety study testing a new experimental drug called ZE74-0282 in healthy volunteers. Researchers want to learn how safe the drug is and how well people tolerate it before testing it in patients with a disease.
This study compares two similar medications (HIP2503 and HCP1306) in healthy volunteers to see how the body processes them and if they are safe. It helps researchers understand if one works better or has different side effects.
Hear when a new Healthy Volunteers trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.